Stocks360

Integrated Pharmaceuticals, Inc. (INTP)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

Share: Facebook X WhatsApp SMS
$0.00

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$1.79K
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
5.37
Day Range
$0.00 – $0.00
52-wk Range
$0.00 – $0.00
Avg Volume
N/A
Volume
2.00K

Integrated Pharmaceuticals, Inc. (INTP) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $1.79K. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Integrated Pharmaceuticals, Inc.

Integrated Pharmaceuticals, Inc., established in 1969 and based in Fitchburg, Massachusetts, operates across the United States, focusing on the creation and manufacturing of specialized chemicals and nutritional supplements. The company's diverse portfolio includes compounds and nutraceuticals scientifically proven to offer therapeutic or nutritive benefits for humans, plants, and animals. It also pioneers advancements in production methods for potent pharmaceutical ingredients, encompassing active small molecular drugs and products derived from recombinant DNA technology. Additionally, Integrated Pharmaceuticals supplies calcium enrichments designed for integration into a wide array of consumables, such as soft drinks, coffee, tea, soups, powdered sauces, various other beverages, and enhanced bottled water. Its products are distributed via a network of wholesale distributors and direct-to-consumer retailers. The firm adopted its current name in September 2011, having previously operated as Digital Caddies, Inc.

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap